These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24528425)

  • 21. Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget's disease.
    Polyzos SA; Anastasilakis AD; Litsas I; Efstathiadou Z; Kita M; Arsos G; Moralidis E; Papatheodorou A; Terpos E
    J Bone Miner Metab; 2010 Nov; 28(6):706-12. PubMed ID: 20533067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of a single dose of zoledronic acid in a case of Paget bone disease].
    Saban M; Fidalgo S; Díaz CA; Lutfi RJ
    Medicina (B Aires); 2010; 70(5):445-8. PubMed ID: 20920964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Optimizing therapy in Paget disease].
    Füessl HS
    MMW Fortschr Med; 2005 Dec; 147(51-52):32. PubMed ID: 16402704
    [No Abstract]   [Full Text] [Related]  

  • 24. Acute Bilateral Anterior Uveitis after a Single Intravenous Infusion of Zoledronic Acid in Metastatic Breast Cancer.
    Jun JH
    Korean J Ophthalmol; 2017 Aug; 31(4):368-369. PubMed ID: 28682020
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacist-run zoledronic acid clinic.
    Traina AN; Kane MP; Bakst G; Abelseth JM; Busch RS
    Am J Health Syst Pharm; 2011 Aug; 68(15):1399-403. PubMed ID: 21785027
    [No Abstract]   [Full Text] [Related]  

  • 26. Osteonecrosis of the jaw.
    Sari E; Bulut N; Altundag K
    J Am Dent Assoc; 2008 Apr; 139(4):398; author reply 398-400. PubMed ID: 18385020
    [No Abstract]   [Full Text] [Related]  

  • 27. Spontaneously recovered severe thrombocytopaenia following zoledronic acid infusion for osteoporosis.
    Kulkarni P; Cushman T; Donthireddy V; Rao S
    BMJ Case Rep; 2016 Feb; 2016():. PubMed ID: 26843222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiresorptive effect of a single infusion of microgram quantities of zoledronate in Paget's disease of bone.
    Arden-Cordone M; Siris ES; Lyles KW; Knieriem A; Newton RA; Schaffer V; Zelenakas K
    Calcif Tissue Int; 1997 May; 60(5):415-8. PubMed ID: 9115157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zoledronic acid-induced transient hepatotoxicity in a patient effectively treated for Paget's disease of bone.
    Polyzos SA; Kountouras J; Anastasilakis AD; Litsas I; Kita M; Arsos G; Moralidis E; Terpos E
    Osteoporos Int; 2011 Jan; 22(1):363-7. PubMed ID: 20407889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget's disease of bone.
    Garnero P; Christgau S; Delmas PD
    Bone; 2001 May; 28(5):461-4. PubMed ID: 11344044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Annual zoledronic acid for osteoporosis.
    BMJ Group
    Drug Ther Bull; 2008 Dec; 46(12):93-6. PubMed ID: 19056701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Remission over 3 years in patients with Paget disease of bone treated with a single intravenous infusion of 5 mg zoledronic acid.
    Devogelaer JP; Geusens P; Daci E; Gielen E; Denhaerynck K; Macdonald K; Hermans C; Vancayzeele S; Abraham I; Boonen S
    Calcif Tissue Int; 2014 Mar; 94(3):311-8. PubMed ID: 24271562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinoma.
    Brizzi MP; Sculli CM; Ragni F; Porpiglia F; Tampellini M; Gorzegno G; Priola AM; Dogliotti L; Berruti A
    Ann Oncol; 2009 Feb; 20(2):389-90. PubMed ID: 19153111
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of single-dose dexamethasone on acute phase response following zoledronic acid: a randomized controlled trial.
    Billington EO; Horne A; Gamble GD; Maslowski K; House M; Reid IR
    Osteoporos Int; 2017 Jun; 28(6):1867-1874. PubMed ID: 28233020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Undetectable Urine Calcium in a Gastric Bypass Patient.
    Campbell ST; Santen RJ; Bruns DE
    Clin Chem; 2016 Aug; 62(8):1161. PubMed ID: 27471247
    [No Abstract]   [Full Text] [Related]  

  • 36. Prolonged anti-resorptive activity of zoledronic acid: evidence from postmenopausal osteopenic women and patients with Paget's disease of bone.
    Polyzos SA
    Clin Rheumatol; 2011 Jan; 30(1):149-50. PubMed ID: 21053036
    [No Abstract]   [Full Text] [Related]  

  • 37. Zoledronic acid and osteonecrosis of the jaw: incidence varies with use.
    Wynn RL
    Gen Dent; 2011; 59(5):330-2. PubMed ID: 22313815
    [No Abstract]   [Full Text] [Related]  

  • 38. Zoledronic acid: new indication. No therapeutic advantage in postmenopausal osteoporosis.
    Prescrire Int; 2008 Aug; 17(96):143. PubMed ID: 19480098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute blepharitis: an unusual complication of zoledronic acid.
    Osta LE; Osta BE
    Int J Rheum Dis; 2017 Apr; 20(4):515-518. PubMed ID: 26412501
    [No Abstract]   [Full Text] [Related]  

  • 40. Zoledronic acid in myeloma: MRC Myeloma IX.
    Rajkumar SV
    Lancet; 2010 Dec; 376(9757):1965-6. PubMed ID: 21131042
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.